{"id":"W4389442202","doi":"10.1212/wnl.92.15_supplement.p1.10-017","title":"Immunogenicity Assessment from Phase 3 Galcanezumab Trials in Patients with Episodic or Chronic Migraine (P1.10-017)","year":2019,"lang":"en","type":"article","venue":"Neurology","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Immunogenicity; Chronic Migraine; Migraine; Medicine; Clinical trial; Internal medicine; Oncology; Immunology; Antigen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005409875,0.0005695058,0.0007581876,0.0002194172,0.0003911936,0.0006699286,0.0003813842,0.0006545887,0.003031139],"category_scores_gemma":[0.003133437,0.0001957583,0.00114293,0.0003367102,0.0002924744,0.000511546,0.0002791984,0.001092861,0.0005400514],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005677834,"about_ca_system_score_gemma":0.0009019429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006621286,"about_ca_topic_score_gemma":0.00146894,"domain_scores_codex":[0.9989801,0.0005878974,0.00008142619,0.00008184114,0.0001338153,0.0001347877],"domain_scores_gemma":[0.9979994,0.0005839479,0.0005846911,0.0001323396,0.0002985223,0.0004011146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6026579,0.01325487,0.07869595,0.003168718,0.01132963,0.0005765342,0.0004539537,0.002846778,0.04014651,0.0005951634,0.01985509,0.2264189],"study_design_scores_gemma":[0.292541,0.4202486,0.2344019,0.0004431475,0.007615948,0.001897792,0.0002443606,0.001686964,0.009696316,0.0006389096,0.03050797,0.00007709691],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9810962,0.00923825,0.0005799871,0.0007327884,0.000190127,0.001642528,0.001558322,0.00003453529,0.004927186],"genre_scores_gemma":[0.9894598,0.002337751,0.0008028182,0.001243558,0.0002825822,0.001317586,0.003309057,0.00001462778,0.001232278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005409875,"threshold_uncertainty_score":0.02861053,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02962969873946074,"score_gpt":0.341186314003546,"score_spread":0.3115566152640852,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}